Form D · Biotechnology
PhysioSonics, Inc
Bellevue, WA · CIK 0001437566
Offering snapshot reported Aug 1, 2012 · SEC filing
- Reported sold
- $1.5M Offering amount: $1.5M
- Investors reported
- 27 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jul 31, 2012 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 1, 2012 | Initial | $1,498,830 | No comparison | 27 | SEC filing |
| Jun 28, 2011 | Initial | $72,750 | No comparison | 5 | SEC filing |
| Feb 4, 2011 | Initial | $3,626,055 | No comparison | 28 | SEC filing |
| Jun 2, 2010 | Initial | $750,000 | No comparison | 1 | SEC filing |
| Mar 17, 2010 | Initial | $25,000 | No comparison | 1 | SEC filing |
| Mar 11, 2010 | Initial | $5,950 | No comparison | 1 | SEC filing |
| Jun 24, 2009 | Initial | $2,000,000 | No comparison | 1 | SEC filing |
| Jun 11, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired, Other
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-182078
Series B Convertible Preferred Stock and warrants and underlying preferred stock to be issued upon exercise of warrants and underlying common stock to be issued upon conversion of preferred stock.
Source: Form D, filed Aug 1, 2012. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Allen Carter | Executive |
| Kirby C. Cramer | Director |
| Craig Drager | Director |
| Robert C.A. Frederickson | Director |
| Brad Harlow | Director, Executive, Promoter |
| Arthur Kirsch | Director |
| Scott Moonly | Director |
| Lauren Pflugrath | Director |
| Michael J. Schuh | Executive |
| Mike Schuh | Executive |
| Michael Weitz | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
2002 156 Th Avenue Ne Ste 150
Bellevue, WA, 98007
Bellevue, WA, 98007